Grafik für die kostenfreie Lieferung in die DACH-Region BÜCHER VERSANDKOSTENFREI INNERHALB DEUTSCHLANDS

Kakar / Westerhoff

Diagnostic Pathology : Hepatobiliary and Pancreas

4. Auflage

Churchill Livingstone

ISBN 978-0-443-38022-8

Standardpreis


ca. 263,50 €

Jetzt vorbestellen! Wir liefern bei Erscheinen (Erscheint vsl. September 2026)

Preisangaben inkl. MwSt. Abhängig von der Lieferadresse kann die MwSt. an der Kasse variieren. Weitere Informationen

Bibliografische Daten

Buch. Hardcover

4. Auflage. 2026

In englischer Sprache

Format (B x L): 21,6 x 27,6 cm

Gewicht: 450

Verlag: Churchill Livingstone

ISBN: 978-0-443-38022-8

Produktbeschreibung

This expert volume in the Diagnostic Pathology series is an excellent point-of-care resource for practitioners at all levels of experience and training. Covering all areas of neoplastic and nonneoplastic diseases of the liver, biliary tree, pancreas, and gallbladder, it incorporates the most recent clinical, pathologic, and molecular knowledge in the field to provide a comprehensive overview of all key issues relevant to today’s practice. Richly illustrated and easy to use, the fourth edition of Diagnostic Pathology: Hepatobiliary and Pancreas is an essential text for accurate, complete pathology reports, ideal as a day-to-day reference or as a reliable, one-stop training resource.

  • Presents clear delineations in challenging diagnoses for both nonneoplastic and neoplastic settings, illustrates novel tumor variants, uses updated terminology and society guidelines, and summarizes the role of molecular findings for diagnosis
  • Analyzes hundreds of diagnoses, each of which include critical diagnostic information such as definitions, epidemiology, clinical presentation, macro- and microscopic features, differential diagnoses, and pathologic interpretation pearls
  • Details the increasing use of molecular methods to diagnose cholestatic biliary liver conditions and other liver diseases of unknown etiology
  • Notes critical recent terminology changes, such as the switch from non-alcoholic fatty liver disease (NAFLD) to metabolic dysfunction-associated steatotic liver disease (MASLD)
  • Explains novel variants of hepatocellular tumors and cholangiocarcinoma, and illustrates the integration of genomic findings in establishing the diagnosis and subclassification of tumors
  • Features more than 1,400 high-quality print images (with an additional 250+ images in the complimentary eBook), including histology and gross pathology images, full-color medical illustrations, clinical photographs, and radiology images
  • Reflects the most recent information from the 6th edition WHO Classification of Tumours, Digestive System Tumours, the American Association for the Study of Liver Disease (AASLD), and the European Association for the Study of the Liver (EASL), including new AASLD guidelines for hepatocellular carcinoma (HCC) and EASL guidelines for cholangiocarcinoma
  • Features a templated, highly formatted design; concise, bulleted text; key facts in each chapter; and an extensive index for easy reference
  • Includes a complimentary eBook with access to everything in the print version as well as additional text, figures, and references, with the ability to search, customize your content, make notes and highlights, and have content read aloud; additional digital ancillary content may publish up to 6 weeks following the publication date

Autorinnen und Autoren

Produktsicherheit

Derzeit sind keine Informationen zur Produktsicherheit verfügbar. Wir arbeiten daran, diese Informationen in naher Zukunft für Sie bereitzustellen.

Topseller & Empfehlungen für Sie

Ihre zuletzt angesehenen Produkte

Rezensionen

Dieses Set enthält folgende Produkte:
    Auch in folgendem Set erhältlich:

    • nach oben

      Ihre Daten werden geladen ...